CRB-701

On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev
Fierce Biotech
Mon, 02/13/23 - 10:29 am
Corbus Pharmaceuticals
Seagen
Padcev
CRB-701
oncology